Market Research Logo

Global Biochips Markets Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022

Global Biochips Markets Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022

The global biochips market is anticipated to grow at a CAGR of 18.4 % during 2016 to 2022. The market has generated the revenue $7.63 Billion in 2016 and is anticipated to reach up to $ 17.65 Billion by 2022. The major driving forces for the market of biochips are Rise in diagnosis & treatment of cancer, Increase Government funding, Growth in personalized medicine and Technical advances.

In today’s world the eczema and food allergies become the most common chronic non-communicable diseases in children in several courtesies.It is seen that more than 8% population are suffering from food allergy, globally in which approximately 6% aged 0-2 years have a food allergy Due to the increase in number of chronic cases such as asthma and multiple sclerosis and diseases like cancer and diabetes increased the demand of diagnosis globally which increased the market of biochip worldwide. According to world health organization in 2015 it has seen that in U.S. more than 1658370 new cancer cases had come in which more than 848200 male cancer cases are there and 810170 female cancer cases.

The global biochips market is segmented on the basis of applications and types. In applications the market is segmented by lab-on-chip (LOC) market, DNA micro array market and protein micro array. Based on types the market is segmented into protein microarray market and other array market DNA microarrays held the largest share segment of biochips market and is expected to holds the largest contributor in the period of 2015-2022.,be followed by lab-on-chip owing to its wide applications and increased adoption by various segments such as pharmaceutical , biotechnology, companies, and research laboratories and the protein microarrays will be the third largest due to advances in the fields of proteomics and genomics.

Geographically the market is segmented into North America, Europe, Asia-Pacific and Rest of World. North America dominates the global biochips market owing to large number of aging population and broad technical applications of biochips followed by Europe and Asia-Pacific. Asia-Pacific market will drive the growth of the market in future owing to growing economies like India and China.

Some of the major players of the market are Thermofisher, Agilent technologies Inc, Biochain institute Inc, Biomérieux sa, Bio-rad laboratories Inc, Caliper life sciences in, Cepheid In, Cybrdi Inc. Emd Millipore, Fluidigm corp, Gamida for life group, Illumina Inc, Imgenex, Life technologies corp, Origene technologies Inc. Acquisition, merger, innovation and new product launch are the major technologies which helps to sustain in the market. In 2016,thermofisher a US based company has announced that they had completed the acquisition of Affymetrix Inc, a US based company that provides cellular and genetic analytics products.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. MARKET SCOPE
2. MARKET OVERVIEW
2.1. GLOBAL BIOCHIPS MARKET: EVOLUTION & TRANSITION
2.2. INDUSTRY STRUCTURE
2.3. MANUFACTURING PROCESS
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. PRICING ANALYSIS
2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7.7. ROI ANALYSIS
2.7.8. GAP ANALYSIS
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES AND ANALYSIS
2.8.2. MARKET SHARE
2.8.3. TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS & MARKET IMPACT
3.1.1. RISE IN DIAGNOSIS & TREATMENT OF CANCER
3.1.2. INCREASE GOVERNMENT FUNDING
3.1.3. GROWTH IN PERSONALIZED MEDICINE
3.1.4. TECHNICAL ADVANCES
3.2. MARKET RESTRAINTS & MARKET IMPACT
3.2.1. LACK OF HEALTHCARE COVERAGE RESTRICTS THE ADOPTION
3.2.2. KNOWLEDGE CONSTRAINTS WITH RESPECT TO TECHNICAL KNOW-HOW
3.3. MARKET OPPORTUNITIES
3.3.1. GROWTH OF MARKET IN THE SUB-CONTINENT OF ASIA
3.3.2. WIDENING APPLICATIONS MARKET
3.4. MARKET CHALLENGES
3.4.1. COMPLEXITY OF BIOLOGICAL SYSTEMS
3.4.2. UNCLEAR REGULATORY GUIDELINES
3.4.3. HIGH INSTRUMENTATION COSTS
4. MARKET SEGMENTATION
4.1. GLOBAL BIOCHIPS DNA MICROARRAY MARKET BY APPLICATION 2014-2022 ($ MILLION)
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION
4.1.5.1. GENE EXPRESSION 2014-2022 ($ MILLION)
4.1.5.1.1. APPLICATIONS
4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.1.5. KEY CONCLUSIONS
4.1.5.2. SNP GENOTYPE 2014-2022 ($ MILLION)
4.1.5.2.1. APPLICATIONS
4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.2.5. KEY CONCLUSIONS
4.1.5.3. CANCER DIAGNOSIS & TREATMENT 2014-2022 ($ MILLION)
4.1.5.3.1. APPLICATIONS
4.1.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.1.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.3.5. KEY CONCLUSIONS
4.1.5.4. GENOMICS 2014-2022 ($ MILLION)
4.1.5.4.1. APPLICATIONS
4.1.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.4.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.1.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.4.5. KEY CONCLUSIONS
4.1.5.5. AGRICULTURAL BIOTECHNOLOGY 2014-2022 ($ MILLION)
4.1.5.5.1. APPLICATIONS
4.1.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.5.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.1.5.5.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.5.5. KEY CONCLUSIONS
4.1.5.6. DRUG DISCOVERY 2014-2022 ($ MILLION)
4.1.5.6.1. APPLICATIONS
4.1.5.6.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.6.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.1.5.6.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.6.5. KEY CONCLUSIONS
4.1.5.7. OTHERS 2014-2022 ($ MILLION)
4.1.5.7.1. APPLICATIONS
4.1.5.7.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.7.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.1.5.7.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.7.5. KEY CONCLUSIONS
4.2. GLOBAL BIOCHIPS LAB ON CHIP/MICROFLUIDICS INDUSTRY BY APPLICATION 2014-2022 ($ MILLION)
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION
4.2.5.1. HIGH THROUGHPUT SCREENING 2014-2022 ($ MILLION)
4.2.5.1.1. APPLICATIONS
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GENOMICS 2014-2022 ($ MILLION)
4.2.5.2.1. APPLICATIONS
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.2.5. KEY CONCLUSIONS
4.2.5.3. PROTEOMICS 2014-2022 ($ MILLION)
4.2.5.3.1. APPLICATIONS
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.3.5. KEY CONCLUSIONS
4.2.5.4. DRUG DISCOVERY 2014-2022 ($ MILLION)
4.2.5.4.1. APPLICATIONS
4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.4.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.2.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.4.5. KEY CONCLUSIONS
4.2.5.5. IVD & POC 2014-2022 ($ MILLION)
4.2.5.5.1. APPLICATIONS
4.2.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.5.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.2.5.5.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.5.5. KEY CONCLUSIONS
4.2.5.6. DIAGNOSTICS 2014-2022 ($ MILLION)
4.2.5.6.1. APPLICATIONS
4.2.5.6.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.6.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.2.5.6.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.6.5. KEY CONCLUSIONS
4.2.5.7. OTHERS 2014-2022 ($ MILLION)
4.2.5.7.1. APPLICATIONS
4.2.5.7.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.7.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.2.5.7.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.7.5. KEY CONCLUSIONS
4.3. GLOBAL BIOCHIPS MARKET BY PROTEIN MICRO ARRAY 2014-2022 ($ MILLION)
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION
4.3.5.1. EXPRESSIONAL PROTEIN MICROARRAY 2014-2022 ($ MILLION)
4.3.5.1.1. APPLICATIONS
4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.1.5. KEY CONCLUSIONS
4.3.5.2. FUNCTIONAL PROTEIN MICROARRAY 2014-2022 ($ MILLION)
4.3.5.2.1. APPLICATIONS
4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.2.5. KEY CONCLUSIONS
4.3.5.3. REVERSE PHASE PROTEIN MICROARRAY 2014-2022 ($ MILLION)
4.3.5.3.1. APPLICATIONS
4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.3.5. KEY CONCLUSIONS
4.3.5.4. EXPRESSION PROFILING 2014-2022 ($ MILLION)
4.3.5.4.1. APPLICATIONS
4.3.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.4.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.3.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.4.5. KEY CONCLUSIONS
4.3.5.5. PROTEOMICS 2014-2022 ($ MILLION)
4.3.5.5.1. APPLICATIONS
4.3.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.5.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.3.5.5.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.5.5. KEY CONCLUSIONS
4.3.5.6. DIAGNOSTICS 2014-2022 ($ MILLION)
4.3.5.6.1. APPLICATIONS
4.3.5.6.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.6.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.3.5.6.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.6.5. KEY CONCLUSIONS
4.3.5.7. DRUG DISCOVERY 2014-2022 ($ MILLION)
4.3.5.7.1. APPLICATIONS
4.3.5.7.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.7.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.3.5.7.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.7.5. KEY CONCLUSIONS
4.3.5.8. OTHERS 2014-2022 ($ MILLION)
4.3.5.8.1. APPLICATIONS
4.3.5.8.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.8.3. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
4.3.5.8.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.8.5. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF M&A
5.1.2. LIST OF JV
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIP
5.2. TOP 10 COMPANY ANALYSIS – DASHBOARD
6. GLOBAL BIOCHIPS MARKET MARKET BY REGION (REVENUE ANALYSIS) 2014-2022 ($ MILLION)
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GEOGRAPHIC SEGMENTATION
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY APPLICATION ANALYSIS
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
6.4.1.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.1.2.1.3. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.4. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
6.4.1.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.1.2.2.3. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.4. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY APPLICATION ANALYSIS
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
6.4.2.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.2.2.1.3. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.4. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
6.4.2.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.2.2.2.3. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.4. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
6.4.2.2.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.2.2.3.3. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.4. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
6.4.2.2.4.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.2.2.4.3. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.4. KEY CONCLUSIONS
6.4.2.2.5. ITALY
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
6.4.2.2.5.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.2.2.5.3. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.4. KEY CONCLUSIONS
6.4.2.2.6. REST OF EUROPE
6.4.2.2.6.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
6.4.2.2.6.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.2.2.6.3. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.6.4. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY APPLICATION ANALYSIS
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
6.4.3.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.3.2.1.3. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.4. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
6.4.3.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.3.2.2.3. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.4. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
6.4.3.2.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.3.2.3.3. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.4. KEY CONCLUSIONS
6.4.3.2.4. SOUTH KOREA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
6.4.3.2.4.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.3.2.4.3. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.4. KEY CONCLUSIONS
6.4.3.2.5. AUSTRALIA
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
6.4.3.2.5.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.3.2.5.3. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.4. KEY CONCLUSIONS
6.4.3.2.6. REST OF ASIA PACIFIC
6.4.3.2.6.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
6.4.3.2.6.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.3.2.6.3. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.6.4. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY APPLICATION ANALYSIS
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
6.4.4.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.4.2.1.3. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.4. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECAST 2014-2022 ($ MILLION)
6.4.4.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.4.2.2.3. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.4. KEY CONCLUSIONS
7. COMPANY PROFILES
7.1. AFFYMETRIX INC
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION SECTOR
7.1.4. STRATEGIC INITIATIVES
7.1.5. SCOT ANALYSIS
7.2. AGILENT TECHNOLOGIES INC
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION SECTOR
7.2.4. STRATEGIC INITIATIVES
7.2.5. SCOT ANALYSIS
7.3. BIOCHAIN INSTITUTE INC
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION SECTOR
7.3.4. STRATEGIC INITIATIVES
7.3.5. SCOT ANALYSIS
7.4. BIOMÉRIEUX SA
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION SECTOR
7.4.4. STRATEGIC INITIATIVES
7.4.5. SCOT ANALYSIS
7.5. BIO-RAD LABORATORIES INC
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION SECTOR
7.5.4. STRATEGIC INITIATIVES
7.5.5. SCOT ANALYSIS
7.6. CALIPER LIFE SCIENCES IN
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION SECTOR
7.6.4. STRATEGIC INITIATIVES
7.6.5. SCOT ANALYSIS
7.7. CEPHEID INC
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION SECTOR
7.7.4. STRATEGIC INITIATIVES
7.7.5. SCOT ANALYSIS
7.8. CYBRDI INC
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION SECTOR
7.8.4. STRATEGIC INITIATIVES
7.8.5. SCOT ANALYSIS
7.9. EMD MILLIPORE
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION SECTOR
7.9.4. STRATEGIC INITIATIVES
7.9.5. SCOT ANALYSIS
7.10. FLUIDIGM CORP
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION SECTOR
7.10.4. STRATEGIC INITIATIVES
7.10.5. SCOT ANALYSIS
7.11. GAMIDA FOR LIFE GROUP
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION SECTOR
7.11.4. STRATEGIC INITIATIVES
7.11.5. SCOT ANALYSIS
7.12. ILLUMINA INC
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION SECTOR
7.12.4. STRATEGIC INITIATIVES
7.12.5. SCOT ANALYSIS
7.13. IMGENEX
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION SECTOR
7.13.4. STRATEGIC INITIATIVES
7.13.5. SCOT ANALYSIS
7.14. LIFE TECHNOLOGIES CORP
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION SECTOR
7.14.4. STRATEGIC INITIATIVES
7.14.5. SCOT ANALYSIS
7.15. ORIGENE TECHNOLOGIES INC
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION SECTOR
7.15.4. STRATEGIC INITIATIVES
7.15.5. SCOT ANALYSIS
LIST OF TABLES
GLOBAL BIOCHIPS MARKET BY APPLICATION 2014-2022 ($ MILLION)
GLOBAL GENE EXPRESSION BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL SNP GENOTYPE BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIPS MARKET IN CANCER DIAGNOSIS & TREATMENT BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIPS MARKET IN GENOMICS BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIPS MARKET IN AGRICULTURAL BIOTECHNOLOGY BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIPS MARKET IN DRUG DISCOVERY BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIPS MARKET MARKET IN OTHERS BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY BY APPLICATION 2014-2022 ($ MILLION)
GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY IN HIGH THROUGHPUT SCREENING BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY IN GENOMICS BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY IN PROTEOMICS BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY IN DRUG DISCOVERY BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY IN IVD & POC BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY IN DIAGNOSTICS BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY IN OTHERS BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP PROTEIN MICRO ARRAY IN EXPRESSIONAL PROTEIN MICROARRAY BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP PROTEIN MICRO ARRAY IN FUNCTIONAL PROTEIN MICROARRAY BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP PROTEIN MICRO ARRAY IN REVERSE PHASE PROTEIN MICROARRAY BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP PROTEIN MICRO ARRAY IN EXPRESSION PROFILING BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP PROTEIN MICRO ARRAY IN PROTEOMICS BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP PROTEIN MICRO ARRAY IN HIGH THROUGHPUT SCREENING BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP PROTEIN MICRO ARRAY IN DIAGNOSTICS BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP PROTEIN MICRO ARRAY IN DRUG DISCOVERY BY GEOGRAPHY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP PROTEIN MICRO ARRAY IN OTHERS BY GEOGRAPHY 2014-2022 ($ MILLION)
NORTH AMERICA BIOCHIPS MARKET 2014-2022 ($ MILLION)
EUROPE BIOCHIPS MARKET 2014-2022 ($ MILLION)
ASIA PACIFIC BIOCHIPS MARKET 2014-2022 ($ MILLION)
REST OF THE WORLD BIOCHIPS MARKET 2014-2022 ($ MILLION)
LIST OF FIGURES
GLOBAL BIOCHIP DNA MICROARRAY INDUSTRY BY GENE EXPRESSION 2014-2022 ($ MILLION)
GLOBAL BIOCHIP DNA MICROARRAY INDUSTRY BY SNP GENOTYPE 2014-2022 ($ MILLION)
GLOBAL BIOCHIP DNA MICROARRAY INDUSTRY BY CANCER DIAGNOSIS & TREATMENT 2014-2022 ($ MILLION)
GLOBAL BIOCHIP DNA MICROARRAY INDUSTRY BY GENOMICS 2014-2022 ($ MILLION)
GLOBAL BIOCHIP DNA MICROARRAY INDUSTRY BY AGRICULTURAL BIOTECHNOLOGY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP DNA MICROARRAY INDUSTRY BY DRUG DISCOVERY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP DNA MICROARRAY INDUSTRY BY OTHERS 2014-2022 ($ MILLION)
GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY BY HIGH THROUGHPUT SCREENING 2014-2022 ($ MILLION)
GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY BY GENOMICS 2014-2022 ($ MILLION)
GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY BY PROTEOMICS 2014-2022 ($ MILLION)
GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY BY DRUG DISCOVERY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY BY IVD & POC 2014-2022 ($ MILLION)
GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY BY DIAGNOSTICS 2014-2022 ($ MILLION)
GLOBAL BIOCHIP LAB ON CHIP/MICROFLUIDICS INDUSTRY BY OTHERS 2014-2022 ($ MILLION)
GLOBAL BIOCHIP PROTEIN MICRO ARRAY MARKET BY EXPRESSIONAL PROTEIN MICROARRAY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP PROTEIN MICRO ARRAY MARKET BY FUNCTIONAL PROTEIN MICROARRAY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP PROTEIN MICRO ARRAY MARKET BY REVERSE PHASE PROTEIN MICROARRAY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP PROTEIN MICRO ARRAY MARKET BY EXPRESSION PROFILING 2014-2022 ($ MILLION)
GLOBAL BIOCHIP PROTEIN MICRO ARRAY MARKET BY PROTEOMICS 2014-2022 ($ MILLION)
GLOBAL BIOCHIP PROTEIN MICRO ARRAY MARKET BY HIGH THROUGHPUT SCREENING 2014-2022 ($ MILLION)
GLOBAL BIOCHIP PROTEIN MICRO ARRAY MARKET BY DIAGNOSTICS 2014-2022 ($ MILLION)
GLOBAL BIOCHIP PROTEIN MICRO ARRAY MARKET BY DRUG DISCOVERY 2014-2022 ($ MILLION)
GLOBAL BIOCHIP PROTEIN MICRO ARRAY MARKET BY OTHERS 2014-2022 ($ MILLION)
UNITED STATES (U.S.) BIOCHIPS MARKET 2014-2022 ($ MILLION)
CANADA BIOCHIPS MARKET 2014-2022 ($ MILLION)
UNITED KINGDOM (UK) BIOCHIPS MARKET 2014-2022 ($ MILLION)
FRANCE BIOCHIPS MARKET 2014-2022 ($ MILLION)
GERMANY BIOCHIPS MARKET 2014-2022 ($ MILLION)
SPAIN BIOCHIPS MARKET 2014-2022 ($ MILLION)
ITALY BIOCHIPS MARKET 2014-2022 ($ MILLION)
ROE BIOCHIPS MARKET 2014-2022 ($ MILLION)
INDIA BIOCHIPS MARKET 2014-2022 ($ MILLION)
CHINA BIOCHIPS MARKET 2014-2022 ($ MILLION)
JAPAN BIOCHIPS MARKET 2014-2022 ($ MILLION)
KOREA BIOCHIPS MARKET 2014-2022 ($ MILLION)
AUSTRALIA BIOCHIPS MARKET 2014-2022 ($ MILLION)
ROAPAC BIOCHIPS MARKET 2014-2022 ($ MILLION)
LATIN AMERICA BIOCHIPS MARKET 2014-2022 ($ MILLION)
MENA BIOCHIPS MARKET 2014-2022 ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report